Autoimmune Connect –
This year has given people a lot of reasons to think about the air they breathe. For example, the summer’s West Coast fires released an immense amount of smoke and ash into the air. The resultant poor air quality is worrying for everyone. But even more so for the autoimmune
Digital GI Health: Sam Holliday, CEO, Oshi Health – Part 2
Coordinating primary with specialty care, redesigning virtual GI care around patients
A continuation of Part 1. One of our B2B thought leadership interviews with digital health entrepreneurs working to improve care of chronic conditions. We care particularly about chronic immunoinflammatory disorders (CIIDs), e.g., autoimmune and autoinflammatory diseases. This continues our interview with CEO of Oshi Health, Sam Holliday. Oshi Health is
Digital GI Health – Sam Holliday, CEO, Oshi Health – Part 1 of 2
On post-COVID telehealth, digital healthcare, virtual-first primary and specialty care, and building the future of GI care
First 2021 post in our series of B2B thought leadership interviews with visionary digital health entrepreneurs working to improve care of chronic conditions. In keeping with our mission, we particularly care about chronic immunoinflammatory disorders (CIIDs), e.g., autoimmune and autoinflammatory diseases. Bonnie and Ellen were happy to finally interview digital
Post-Viral Syndromes – A History of Neglect (Long COVID Part 2)
The emergence of post-Covid syndrome shines new light on post-viral syndromes
The emergence of post-COVID syndrome shines new light on the old problem of post-viral syndromes In Part 1, we discussed how the rise of long covid shines new light on chronic post-viral disorders long ignored by researchers and clinicians. But this issue didn’t just appear with the SARS-COV-2 COVID-19 pandemic.
Will long-COVID activists, especially practitioner-patients, finally force healthcare systems, clinicians and medical researchers to confront post-viral and similar chronic syndromes they have shrugged off for decades? In keeping with our mission, will a focused response by healthcare systems and researchers to post-COVID syndrome help illuminate the invisible epidemic of autoimmune and autoinflammatory disorders?
Chase Spurlock, PhD, Founder & CEO of Decode Health, on Predictive Data Analytics for COVID-19 & Chronic Disease*
Dr Bonnie 360 interviews Chase Spurlock, PhD, founder and CEO of Decode Health on AI analytics in COVID and chronic inflammatory disease.